Icon

SYMBYAX (nda021520)- (EQ 25MG BASE;EQ 3MG BASE,EQ 25MG BASE;EQ 6MG BASE,EQ 50MG BASE;EQ 6MG BASE,EQ 25MG BASE;EQ 12MG BASE,EQ 50MG BASE;EQ 12MG BASE)

FLUOXETINE HYDROCHLORIDE; OLANZAPINE LILLY
EQ 25MG BASE;EQ 3MG BASE,EQ 25MG BASE;EQ 6MG BASE,EQ 50MG BASE;EQ 6MG BASE,EQ 25MG BASE;EQ 12MG BASE,EQ 50MG BASE;EQ 12MG BASE
Yes No
2017-Nov-01 Expired
None None
None No
SYMBYAX® combines olanzapine, an atypical antipsychotic and fluoxetine, a selective serotonin reuptake inhibitor, indicated for treatment of: • Acute Depressive Episodes Associated with Bipolar I Disorder • Treatment Resistant Depression
4 0 3
Total Other Developers None
Drugs with Suitability No
EQ 25MG BASE;EQ 3MG BASE ** ** - 2 -
EQ 25MG BASE;EQ 6MG BASE ** ** - 2 -
EQ 50MG BASE;EQ 6MG BASE ** ** - - 2
EQ 25MG BASE;EQ 12MG BASE ** ** - - 2
EQ 50MG BASE;EQ 12MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.